One day, the SpaceX Starship may take us back to the moon -- but first, it needs to get off of Earth.
Hope springs eternal, but airlines may have to wait for winter to get their newest 737s back in service.
An acquisition bid falls through.
Lockheed Martin has its F-35 fighter jet. What's left for Boeing to build?
Sir Richard Branson is really excited about taking his space tourism company public. Should you be, too?
But could this pose a greater threat to Boeing and Lockheed's United Launch Alliance than it does to SpaceX?
These three companies are suddenly radioactive on news their quota requests have been rejected.
Goldman Sachs may love Stitch Fix, but not all investors are convinced.
Analysts see no profits in Snap's foreseeable future -- but one banker likes it anyway.
Give a hoot -- don't dilute. Or is dilution okay if it's a marijuana stock?
It's an M&A miracle!
Fears of dilution give way to appreciation of cash.
The prospect of an extra $100 billion in revenue proves too good for Cowen to pass up.
One Wall Street analyst took investor confidence away, then another returned bit of it.
The prospect of 40% revenue growth proves too great to resist.
Here's why one analyst likes this mobile phone service provider.
European space firms are eyeing a Low Earth Orbit acquisition of Maxar's beleaguered space-tech business.
Two executives resign. Whether they jumped or were pushed may not even matter.
After doubling in less than a month, do the shares still have room to run?
Is 3.9 times earnings cheap? Yes. But other valuation metrics tell a different story.